N-Acetylglucosamine
- Generic Name
- N-Acetylglucosamine
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C8H15NO6
- CAS Number
- 7512-17-6
- Unique Ingredient Identifier
- V956696549
- Background
The N-acetyl derivative of glucosamine.
- Indication
For the treatment and prevention of osteoarthritis, by itself or in combination with chondroitin sulfate.
- Associated Conditions
- -
- Associated Therapies
- -
Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
Phase 3
- Conditions
- Interventions
- First Posted Date
- 2015-07-21
- Last Posted Date
- 2015-07-21
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 720
- Registration Number
- NCT02504060
- Locations
- 🇨🇳
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Multicenter Withdrawal Clinical Trials of N-acetyl Glucosamine Capsule for IBS-D Treatment
- First Posted Date
- 2013-07-09
- Last Posted Date
- 2015-07-24
- Lead Sponsor
- Third Military Medical University
- Target Recruit Count
- 180
- Registration Number
- NCT01893606
- Locations
- 🇨🇳
Daping hospital, Chongqing, Chongqing, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath